Skip to main content
. 2020 Feb 6;39(4):e30–e36. doi: 10.1097/INF.0000000000002580

FIGURE 3.

FIGURE 3.

Vaccine efficacy against symptomatic VCD between doses in participants who were seropositive (A) or seronegative (B) at baseline in Colombia. Serostatus Determined By Prnt (Measured Or Imputed) At Month 0 In A Subcohort Of Participants. N And N Are Average Numbers From 10 Iterations Of Multiple Imputations. Study Group Classified As Randomized (Subjects Classified According To The Injection Assigned At Randomization). Eap Indicates End Of The Active Phase; N: Total Number Of Subjets Selected In Sub-Cohort; N, Number Of Subjects Fulfilling The Item Listed.